JPMorgan Chase falls after quarterly profit at the bank declines 7%.

We recently published 10 Stocks Jim Cramer Talked About. Moderna Inc. (NASDAQ:MRNA) is one of the stocks on Jim Cramer talked ...

Moderna shares surge 30% in 2026 on raised revenue forecast and cost cuts. Technical breakout suggests continued momentum ...

Moderna shares are volatile Monday after the company provided updates on its business and pipeline at a healthcare conference ...

On Tuesday, Moderna MRNA got a positive adjustment to its Relative Strength (RS) Rating, from 67 to 73. This exclusive rating ...

Massachusetts-based Moderna Inc. is seeing fresh momentum in recent weeks, with the stock off to a flying start in 2026.

Moderna pivots to infectious disease & oncology, targeting cash break-even by 2028. Click here to see why I rate MRNA stock a ...

Moderna will release its fourth-quarter earnings soon, and analysts anticipate a low double-digit loss decline.

Stocks that are trending today. Stéphane Bancel, CEO of Moderna , said: "We remain focused on our strategy to build a large ...

On January 12, 2026, Moderna reported that it expected unaudited 2025 revenue of about $1.9 billion—slightly above prior guidance—alongside improved projected 2025 GAAP operating expenses of $5.0–$5.2 ...

Caterpillar CAT stock rose toward closing with a market cap of more than $300 billion for the first time ever, according to ...

Argus Research analyst Jasper Hellweg reiterated a Hold rating on Moderna yesterday. The company’s shares closed yesterday at $39.60. According to TipRanks, Hellweg is a 4-star analyst with an average ...